Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
LEO Pharma |
---|---|
Information provided by: | LEO Pharma |
ClinicalTrials.gov Identifier: | NCT00392067 |
To compare the efficacy and safety of two different dose combinations of LEO19123 (calcipotriol and LEO80122) with LEO19123 cream vehicle for 3 weeks in the treatment of patients with atopic dermatitis
Condition | Intervention | Phase |
---|---|---|
Atopic Dermatitis |
Drug: Calcipotriol and LEO80122 (LEO19123 cream) |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | LEO19123 Cream in the Treatment of Atopic Dermatitis |
Ages Eligible for Study: | 18 Years to 50 Years |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Canada, Quebec | |
Clinique Dermatologique Maizerets | |
Quebec City, Quebec, Canada, G1J 1X7 | |
Denmark | |
Hudklinikken | |
Nykøbing F, Denmark, 4800 | |
Finland | |
Helsinki University Central Hospital | |
Helsinki, Finland, 00250 | |
United Kingdom | |
Manchester Royal Infirmary | |
Manchester, United Kingdom, M13 9WL |
Principal Investigator: | Kristian Thestrup-Pedersen, MD | Hudklinikken |
Study ID Numbers: | LEO19123-C21 |
Study First Received: | October 24, 2006 |
Last Updated: | April 29, 2008 |
ClinicalTrials.gov Identifier: | NCT00392067 History of Changes |
Health Authority: | Canada: Health Canada; Denmark: Danish Medicines Agency; Finland: National Agency for Medicines; United Kingdom: Medicines and Healthcare Products Regulatory Agency |
Calcipotriene Hypersensitivity Dermatitis, Atopic Genetic Diseases, Inborn Skin Diseases |
Hypersensitivity, Immediate Skin Diseases, Eczematous Skin Diseases, Genetic Dermatitis |
Dermatitis, Atopic Skin Diseases Immune System Diseases Pharmacologic Actions Calcipotriene Hypersensitivity Genetic Diseases, Inborn |
Therapeutic Uses Hypersensitivity, Immediate Skin Diseases, Eczematous Skin Diseases, Genetic Dermatologic Agents Dermatitis |